Home

Michael Jay Ross

CIK 1254452 · last filed 2022-06-17

Michael Jay Ross is a corporate insider who has filed 19 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing, for XLO, was dated Jun 17, 2022. Across all open-market trades the lifetime net is +$5.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $373.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$373.8K

Companies

6

Total Filings

19

Lifetime Open-Market Net

$5.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XLO Director — $8.31 — $0 2 2022-06-17
Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Director — $25.59 — $0 2 2019-06-13
STRO Director 12,928 $28.80 $372.3K $0 2 2018-10-01
IVERIC bio, Inc. (OPHT) Delisted Director 3,500 — — $0 5 2018-07-11
Astria Therapeutics, Inc. (CATB) Delisted Director — $8.54 — $0 4 2018-06-07
ASNS Director 19,128 $0.08 $1.5K $5.00M 4 2018-06-07

Recent Filings

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-17 XLO Grant (A) — $0 EDGAR
2021-10-25 XLO Grant (A) — $0 EDGAR
2019-06-13 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Grant (A) — $0 EDGAR
2018-10-01 STRO Mixed +1,824,542 $0 EDGAR
2018-09-27 STRO Grant (A) — $0 EDGAR
2018-07-11 IVERIC bio, Inc. (OPHT) Delisted Grant (A) — $0 EDGAR
2018-06-07 Astria Therapeutics, Inc. (CATB) Delisted Grant (A) — $0 EDGAR
2018-06-07 ASNS Grant (A) — $0 EDGAR
2018-05-21 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Grant (A) — $0 EDGAR
2018-03-05 ASNS Grant (A) — $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.